İ. T. Çöllüoğlu Et Al. , "Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy," International Journal of Cardiology , vol.407, 2024
Çöllüoğlu, İ. T. Et Al. 2024. Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy. International Journal of Cardiology , vol.407 .
Çöllüoğlu, İ. T., Çelik, A., Ata, N., Ural, D., ŞAHİN, A., Ulgu, M. M., ... Kanık, E. A.(2024). Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy. International Journal of Cardiology , vol.407.
Çöllüoğlu, İnci Et Al. "Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy," International Journal of Cardiology , vol.407, 2024
Çöllüoğlu, İnci T. Et Al. "Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy." International Journal of Cardiology , vol.407, 2024
Çöllüoğlu, İ. T. Et Al. (2024) . "Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy." International Journal of Cardiology , vol.407.
@article{article, author={İnci Tuğçe Çöllüoğlu Et Al. }, title={Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy}, journal={International Journal of Cardiology}, year=2024}